Clinical trial
Impact of Perioperative Dexamethasone and Flurbiprofen Axetil on Delirium After Surgery for Non-small Cell Lung Cancer: A 2x2 Factorial Randomized Controlled Trial
NCT03200600 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Perioperative Dexamethasone and Flurbiprofen Axetil on Delirium After Surgery for Non-small Cell Lung Cancer: A 2x2 Factorial Randomized Controlled Trial
- Lead sponsor
- Peking University First Hospital
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- August 2, 2017
- Completion date
- December 26, 2018
- Enrollment
- 126 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
carcinoma, non-small-cell lung, delirium, dexamethasone, flubiprofen axetil, surgery--complications